{
  "id": 12874921,
  "title": "STAT+: Pharmalittle: We’re reading about PhRMA suing Trump, biotech frustration over tariffs, and more",
  "url": "https://urgent.news/2026/10/08/stat-pharmalittle-were-reading-about-phrma-suing-trump-biotech",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-08T13:15:33.000Z",
  "source": {
    "name": "STAT News",
    "slug": "stat-news",
    "url": "https://www.statnews.com/pharmalot/2026/10/08/phrma-suing-trump-biotech-frustration-tariffs-pharmalittle-newsletter/"
  },
  "original_language": "en",
  "account": "Pharmaceutical manufacturers' trade group PhRMA has filed a lawsuit against the Trump administration, claiming that a Medicare drug price pilot program exceeds Medicare's authority. The pilot, known as GLOBE, ties Medicare Part B drug prices to those in peer countries. However, an exemption for most companies in the program means it likely won't have much impact. Nevertheless, the industry is eager to prevent a precedent from being set. The administration is reportedly working on plans that would allow temporary sales of restricted peptides, enabling compounding pharmacies to distribute certain peptide products despite a lack of full safety testing.",
  "summary": "PhRMA is suing the Trump administration, smaller biotech firms are frustrated over tariffs, and more of the latest pharma news.",
  "key_points": [
    "PhRMA sues Trump administration over Medicare drug price pilot program",
    "GLOBE program ties Medicare Part B drug prices to peer countries",
    "Industry seeks to prevent precedent, administration plans temporary peptide sales"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "STAT News",
        "title": "STAT+: Biotech companies are struggling to navigate Trump’s new tariffs",
        "url": "https://urgent.news/2026/10/08/stat-biotech-companies-are-struggling-to-navigate-trumps-new-tariffs",
        "published": "2026-10-08T08:30:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}